Das George-Huntington-Institut
Dr. Ralf Reilmann - Neurologist

My main interest is to contribute to the development of disease modifying or novel...

Read More
Dr. Dorothea Faulhaber - Fachärztin / Chief Financial Officer

Read More
Dr. Stefan Bohlen - Neurologist

Read More
Anabel Rüsenberg - Physician

Read More
Dr. Herwig Lange - Neurologist

Dr. Lange has been researching Huntington's disease (HD) since 1969 and has described in...

Read More
Dorothee Schulte to Bühne - Study Coordinator

Read More
Svenja Aufenberg - Study Coordinator

Read More
Bea Beule - Study Nurse

Read More
Hasnaa Al-Mawlawi

Read More
Philipp Otten

Read More
Roche Studie Generation-HD1 stoppt weitere Dosierung
March 22, 2021

Die Firma Roche hat in einer Pressemeldung mitgeteilt, dass die Generation-HD1 Studie mit dem...

Read More
PROOF-HD phase III pivotal trial with Pridopidine
September 30, 2020

GHI will shortly start the pivotal phase III trial PROOF-HD with Pridopidine. Several studies...

Read More
SHIELD-HD Study of Triplet Therapeutics started at GHI
September 24, 2020

nan

Read More
Erreichbarkeit während der Umzugsphase
June 22, 2020

Liebe Patienten, Angehörige und Interessenten,

 

aufgrund des Umzugs sind die...

Read More
IDEA-FAST consortium receives € 44 Mio. from EU IMI2/Horizon 2020 program - GHI partner
December 6, 2019

The IMI2 consortium IDEA-FAST receives € 44 Mio. funding in the Horizon 2020 programm of the...

Read More